TABLE 1—
Reporting Completeness for Traditional Methods and Electronic Laboratory Reporting, by Condition: Indianapolis, Ind, 2001
| Condition | Spontaneous Reporting (Public Health Department), No. (%) | Electronic Laboratory Reporting (INPC), No. (%) | No. of Unique Reports |
| Acute herpes | 0 (0.0) | 0 (0.0) | 1 |
| Amebiasis | 0 (0.0) | 1 (100.0) | 1 |
| Blastomycosis | 0 (0.0) | 1 (100.0) | 1 |
| Campylobacteriosis | 3 (60.0) | 3 (60.0) | 5 |
| Chickenpox | 0 (0.0) | 8 (88.9) | 9 |
| Chlamydial infection | 398 (52.5) | 719 (94.9) | 758 |
| Coccidioidomycosis | 0 (0.0) | 1 (100.0) | 1 |
| Cryptococcosis | 0 (0.0) | 9 (100.0) | 9 |
| Cryptosporidiosis | 2 (66.7) | 2 (66.7) | 3 |
| Cytomegalovirus | 0 (0.0) | 116 (100.0) | 116 |
| Ebola | 0 (0.0) | 4 (100.0) | 4 |
| Elevated carboxyhemoglobin level | 0 (0.0) | 65 (100.0) | 65 |
| Enterococcus, vancomycin resistant | 0 (0.0) | 44 (73.3) | 60 |
| Escherichia coli O157:H7 infection | 1 (50.0) | 2 (100.0) | 2 |
| Fifth disease | 0 (0.0) | 9 (100.0) | 9 |
| Giardiasis | 3 (42.9) | 6 (85.7) | 7 |
| Gonorrhea | 228 (56.7) | 383 (95.3) | 402 |
| Haemophilus influenzae | 0 (0.0) | 138 (100.0) | 138 |
| Hepatitis A | 6 (4.0) | 146 (97.3) | 150 |
| Hepatitis B | 20 (3.1) | 635 (99.4) | 639 |
| Hepatitis C | 164 (34.1) | 463 (96.3) | 481 |
| Hepatitis D | 0 (0.0) | 2 (100.0) | 2 |
| Herpes simplex | 0 (0.0) | 35 (100.0) | 35 |
| Herpes simplex type 1 | 0 (0.0) | 37 (100.0) | 37 |
| Herpes simplex type 2 | 0 (0.0) | 61 (100.0) | 61 |
| Histoplasmosis | 4 (12.9) | 30 (96.8) | 31 |
| HIV | 23 (3.7) | 616 (99.5) | 619 |
| Human T-lymphotropic virus | 0 (0.0) | 4 (100.0) | 4 |
| Influenza | 0 (0.0) | 71 (96.0) | 74 |
| Lead exposure | 5 (29.4) | 17 (100.0) | 17 |
| Lyme disease | 0 (0.0) | 2 (100.0) | 2 |
| Meningitis: bacterial | 0 (0.0) | 31 (88.6) | 35 |
| Meningitis: fungal | 0 (0.0) | 0 (0.0) | 1 |
| Meningitis: viral | 0 (0.0) | 0 (0.0) | 2 |
| Meningococcal disease | 0 (0.0) | 2 (100.0) | 2 |
| Mumps | 0 (0.0) | 13 (92.9) | 14 |
| Mycobacterium, nontuberculous | 0 (0.0) | 68 (100.0) | 68 |
| Other | 0 (0.0) | 0 (0.0) | 19 |
| Poliomyelitis | 0 (0.0) | 2 (100.0) | 2 |
| Rubella | 0 (0.0) | 22 (100.0) | 22 |
| Salmonellosis, nontyphoid | 3 (21.4) | 12 (85.7) | 14 |
| Shigellosis | 27 (84.4) | 28 (87.5) | 32 |
| Sickle cell disease | 0 (0.0) | 62 (100.0) | 62 |
| Streptococcus pneumoniae | 30 (53.6) | 45 (80.4) | 56 |
| Streptococcus: group A | 5 (1.3) | 380 (100.0) | 380 |
| Streptococcus: group B | 3 (2.2) | 136 (99.3) | 137 |
| Syphilis | 18 (13.3) | 133 (98.5) | 135 |
| Tetanus | 0 (0.0) | 8 (100.0) | 8 |
| Toxoplasmosis | 0 (0.0) | 4 (100.0) | 4 |
| Trichomoniasis | 0 (0.0) | 41 (100.0) | 41 |
| Tuberculosis | 1 (25.0) | 4 (100.0) | 4 |
| Typhoid fever | 0 (0.0) | 3 (100.0) | 3 |
| Yersiniosis, nonplague | 0 (0.0) | 1 (100.0) | 1 |
Note. INPC = Indiana Network for Patient Care.